SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-323133
Filing Date
2019-12-26
Accepted
2019-12-26 09:32:33
Documents
5
Period of Report
2019-12-26

Document Format Files

Seq Description Document Type Size
1 6-K d856955d6k.htm 6-K 13013
2 EX-99.1 d856955dex991.htm EX-99.1 8950
3 EX-99.2 d856955dex992.htm EX-99.2 27364
4 GRAPHIC g856955g1224230442910.jpg GRAPHIC 4678
5 GRAPHIC g856955snap0001g2.jpg GRAPHIC 11827
  Complete submission text file 0001193125-19-323133.txt   73498
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 001-36866 | Film No.: 191308567
SIC: 2834 Pharmaceutical Preparations